Influence of Manual Relaxation of the Diaphragm on the Tension of the Posterior Superficial Fascia

January 14, 2022 updated by: Roksana Wójcik, Jagiellonian University

The diaphragm performs many functions that are vital to the body as a whole. Some of them are not related only to ventilation. The diaphragm is part of the myofascial system in the human body. Therefore, the proper functioning of the diaphragm should be a significant element of physiotherapy, e.g. in patients reporting pain in the lumbosacral spine.

Considering the complex role of the diaphragm, it seems reasonable to investigate the influence of the mobilization of the diaphragm (aimed at reducing diaphragm tension) on the tension of the extensor muscles of the lumbar spine.

The assumption of this reserach is to investigate the correlation between the tension of the fascia in the area of the diaphragm to the tension of the muscles in the area of the lumbar spine. The fascial connections between the diaphragm and the muscles in the lumbar spine presented above suggest that the manual therapy performed within the diaphragm can effectively prevent the occurrence of pain, and might be a supportive measure in the treatment of pain in the spine.

The aim of the study is to investigate the corellation between the tension of the fascia within the diaphragm and the tension of the posterior superficial tape.

Research questions:

  1. How does manual therapy in the area of the tendon attachments of the diaphragm affect the relaxation of the extensor muscles of the lumbar spine?
  2. How can the therapy conducted only within the diaphragm, without interfering with the structures surrounding the spine, reduce the tension of the extensor muscles of the lumbar spine and, consequently, increase the range of its mobility in all planes?
  3. How will the introduced therapy change the tidal volume of the lungs?

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age within 20-40 yrs,
  • BMI within normal range (18.5-24.9)
  • lack of abdominal obesity
  • lack of chronic musculoskeletal conditions
  • written, conscious consent

Exclusion Criteria:

  • former abdominal surgery
  • abdominal diseases (i.e. (np. kidney stones, ulcers, irritative bowel sindrome, etc.),
  • pregnancy
  • fever,
  • tumors,
  • blood hypertension,
  • former surgery of respiratory system ,
  • condition after surgical procedures in the area of the spine,
  • the occurrence of pain in the spine in the 3 months preceding the research experiment,
  • lack of conscious consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Diaphragm fascial release group.
Ten minutes lasting fascial release techinques performed on diaphragm.
The intervention consists of deep tissue massage techniques and manual mobilization of the fascia performed within the diaphragm attachments in the area of the costal arches.
Placebo Comparator: Classic massage group
Ten minutes lasting classic massage performed on abdomen.
The intervention consists of selected classic massage techniques - mainly stroking (effleurage) - performed on the superficial layers of the abdominal region

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessemnt of change in muscle tension of selected muscles of lumbar region
Time Frame: Twice - before and immediately after the treatment procedure
Assessment of muscle superficial electromyography will be performed with sEMG device NuTrac Alpha2E (NeuroTrac Ltd.) on the following muscles: multifidus, longissimus and iliocostalis.
Twice - before and immediately after the treatment procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of change of range of motion of the lumbar spine.
Time Frame: Twice - before and immediately after the treatment procedure
The range of motion of the lumbar spine will be performed with the digital inclinometer (Baseline)
Twice - before and immediately after the treatment procedure
Assessment of change in peak expiratory flow in one second (PEF1)
Time Frame: Twice - before and immediately after the treatment procedure
The peak expiratory flow in one second will be performed with PF100 peakflometer (Microlife).
Twice - before and immediately after the treatment procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Bartosz Trybulec, PhD, Jagiellonian University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2021

Primary Completion (Anticipated)

March 31, 2022

Study Completion (Anticipated)

July 30, 2022

Study Registration Dates

First Submitted

December 27, 2021

First Submitted That Met QC Criteria

January 14, 2022

First Posted (Actual)

January 20, 2022

Study Record Updates

Last Update Posted (Actual)

January 20, 2022

Last Update Submitted That Met QC Criteria

January 14, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • N43/DBS/000115

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Fascial release of diaphragm muscle.

Subscribe